These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23261601)

  • 61. The solution structure of monomeric CCL5 in complex with a doubly sulfated N-terminal segment of CCR5.
    Abayev M; Rodrigues JPGLM; Srivastava G; Arshava B; Jaremko Ł; Jaremko M; Naider F; Levitt M; Anglister J
    FEBS J; 2018 Jun; 285(11):1988-2003. PubMed ID: 29619777
    [TBL] [Abstract][Full Text] [Related]  

  • 62. HIV-1 drug discovery: targeting folded RNA structures with branched peptides.
    Wynn JE; Santos WL
    Org Biomol Chem; 2015 Jun; 13(21):5848-58. PubMed ID: 25958855
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Minidefensins and other antimicrobial peptides: candidate anti-HIV microbicides.
    Cole AM
    Expert Opin Ther Targets; 2003 Jun; 7(3):329-41. PubMed ID: 12783570
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Rapid and low-cost multiplex synthesis of chemokine analogs.
    Paolini-Bertrand M; Cerini F; Martins E; Scurci I; Hartley O
    J Biol Chem; 2018 Dec; 293(49):19092-19100. PubMed ID: 30305389
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effective lowly cytotoxic analogs of an HIV-cell fusion inhibitor, T22 ([Tyr5,12, Lys7]-polyphemusin II).
    Tamamura H; Arakaki R; Funakoshi H; Imai M; Otaka A; Ibuka T; Nakashima H; Murakami T; Waki M; Matsumoto A; Yamamoto N; Fujii N
    Bioorg Med Chem; 1998 Feb; 6(2):231-8. PubMed ID: 9547946
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Targeted delivery of PSC-RANTES for HIV-1 prevention using biodegradable nanoparticles.
    Ham AS; Cost MR; Sassi AB; Dezzutti CS; Rohan LC
    Pharm Res; 2009 Mar; 26(3):502-11. PubMed ID: 19002569
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Characterization of structure, dynamics, and detergent interactions of the anti-HIV chemokine variant 5P12-RANTES.
    Wiktor M; Hartley O; Grzesiek S
    Biophys J; 2013 Dec; 105(11):2586-97. PubMed ID: 24314089
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Chemotherapeutic interventions targeting HIV interactions with host-associated carbohydrates.
    McReynolds KD; Gervay-Hague J
    Chem Rev; 2007 May; 107(5):1533-52. PubMed ID: 17439183
    [No Abstract]   [Full Text] [Related]  

  • 69. Development of anti-HIV peptides based on a viral capsid protein.
    Mizuguchi T; Ohashi N; Matsumoto D; Hashimoto C; Nomura W; Yamamoto N; Murakami T; Tamamura H
    Biopolymers; 2017 Jan; 108(1):. PubMed ID: 27428649
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Development of an HIV-1 Microbicide Based on Caulobacter crescentus: Blocking Infection by High-Density Display of Virus Entry Inhibitors.
    Farr C; Nomellini JF; Ailon E; Shanina I; Sangsari S; Cavacini LA; Smit J; Horwitz MS
    PLoS One; 2013; 8(6):e65965. PubMed ID: 23840383
    [TBL] [Abstract][Full Text] [Related]  

  • 71. HIV coreceptors.
    Dimitrov DS; Xiao X; Chabot DJ; Broder CC
    J Membr Biol; 1998 Nov; 166(2):75-90. PubMed ID: 9841733
    [No Abstract]   [Full Text] [Related]  

  • 72. Novel structures of self-associating stapled peptides.
    Bhattacharya S; Zhang H; Cowburn D; Debnath AK
    Biopolymers; 2012 May; 97(5):253-64. PubMed ID: 22170623
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Stability of 5P12-RANTES, A Candidate Rectal Microbicide, in Human Rectal Lavage.
    Cerini F; Offord R; McGowan I; Hartley O
    AIDS Res Hum Retroviruses; 2017 Aug; 33(8):768-777. PubMed ID: 28177261
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The role of amphiphilicity and negative charge in glycoprotein 41 interactions in the hydrophobic pocket.
    Gochin M; Cai L
    J Med Chem; 2009 Jul; 52(14):4338-44. PubMed ID: 19534533
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Peptide Amphiphilic-Based Supramolecular Structures with Anti-HIV-1 Activity.
    Gómara MJ; Pons R; Herrera C; Ziprin P; Haro I
    Bioconjug Chem; 2021 Sep; 32(9):1999-2013. PubMed ID: 34254794
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Development of anti-HIV drugs targeted to the coreceptors].
    Murakami T; Yamamoto N
    Tanpakushitsu Kakusan Koso; 1998 Apr; 43(5):677-85. PubMed ID: 9564785
    [No Abstract]   [Full Text] [Related]  

  • 77. Multi-step purification strategy for RANTES wild-type and mutated analogues expressed in a baculovirus system.
    Comuzzi B; Arcelloni C; Polo S; Nardese V; Lusso P; Paroni R
    J Chromatogr B Biomed Sci Appl; 2000 Jan; 737(1-2):47-54. PubMed ID: 10681040
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Anti-HIV screening for cell-penetrating peptides using chloroquine and identification of anti-HIV peptides derived from matrix proteins.
    Mizuguchi T; Ohashi N; Nomura W; Komoriya M; Hashimoto C; Yamamoto N; Murakami T; Tamamura H
    Bioorg Med Chem; 2015 Aug; 23(15):4423-4427. PubMed ID: 26094944
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Enhancement of HIV-1 infectivity by simple, self-assembling modular peptides.
    Easterhoff D; DiMaio JT; Doran TM; Dewhurst S; Nilsson BL
    Biophys J; 2011 Mar; 100(5):1325-34. PubMed ID: 21354406
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Chemoselective oxime reactions in proteins and peptides by using an optimized oxime strategy: the demise of levulinic acid.
    Agten SM; Suylen D; Ippel H; Kokozidou M; Tans G; van de Vijver P; Koenen RR; Hackeng TM
    Chembiochem; 2013 Dec; 14(18):2431-4. PubMed ID: 24151209
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.